Rana Falahat

4PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 03, 2025
Chemokine/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunity.

Rana Falahat, James J Mulé

|Mar 13, 2025
Targeting MARCO in combination with anti-CTLA-4 leads to enhanced melanoma regression and immune cell infiltration via macrophage reprogramming.

Hidenori Takahashi, Patricio Perez-Villarroel, Rana Falahat

|Mar 23, 2023
Epigenetic state determines the in vivo efficacy of STING agonist therapy.

Rana Falahat, Anders Berglund, Patricio Perez-Villarroel

|Apr 08, 2021
Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.

Rana Falahat, Anders Berglund, Ryan M Putney

Pageof 1